CNS clinical trials : suicidality and data collection : workshop summary /

"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders
Otros Autores: Hanson, Sarah L. (Sarah Lynn), 1980-, Davis, Miriam (Medical writer), Altevogt, Bruce M.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2010.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Suicide > United States > Prevention > Congresses.
Suicidal behavior > United States > Congresses.
Clinical health psychology > United States > Congresses.
Clinical trials > United States > Congresses.
Nervous system > Congresses.
Suicide > Prevention.
Mental illness.
Suicide Prevention
Mental Disorders
Suicide > États-Unis > Prévention > Congrès.
Comportement suicidaire > États-Unis > Congrès.
Santé > Psychologie clinique > États-Unis > Congrès.
Études cliniques > États-Unis > Congrès.
Système nerveux > Congrès.
Suicide > Prévention.
Maladies mentales.
mental disorders.
PSYCHOLOGY > Suicide.
Mental illness
Clinical health psychology
Clinical trials
Nervous system
Suicidal behavior
Suicide > Prevention
United States
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Acceso en línea:Texto completo
Descripción
Sumario:"The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description.
Descripción Física:1 online resource (xii, 75 pages) : illustrations
Bibliografía:Includes bibliographical references (pages 43-49).
ISBN:9780309148849
0309148847

Ejemplares similares